Peptide Initiative

Peptides · Peptide comparison

Cerebrolysin vs Semax

Porcine brain-derived neuropeptide preparation containing bioactive peptide fragments of neurotrophic factors, used clinically in over 40 countries for stroke recovery, traumatic brain injury, and cognitive impairment

A brain-boosting peptide that supercharges your cognitive function by ramping up BDNF—the protein your neurons need to grow, connect, and stay sharp—all delivered through a simple nasal spray.

  • Cognitive
  • Cognitive

At a glance

Quick comparison

Dose rangeCerebrolysin20–30 mLSemax500–900 mcg/day
FrequencyCerebrolysinOnce dailySemaxOnce daily
AdministrationCerebrolysinIntravenous (IV) injection or infusionSemaxIntranasal spray
Cycle lengthCerebrolysin8-12 weeksSemax4-6 weeks
Onset speedCerebrolysinModerate (1-2 weeks)SemaxRapid (hours to days)
Evidence levelCerebrolysinModerate human trials (Phase 1-2)SemaxModerate human trials (Phase 1-2)

Efficacy

Benefit ratings

Stroke Recovery

Cerebrolysin78%
SemaxNo recorded rating

Alzheimer's Support

Cerebrolysin72%
SemaxNo recorded rating

Brain Injury Healing

Cerebrolysin65%
SemaxNo recorded rating

Cognitive Enhancement

CerebrolysinNo recorded rating
Semax94%

Neuroprotection

CerebrolysinNo recorded rating
Semax91%

Mental Energy

CerebrolysinNo recorded rating
Semax87%

Technical data

Compound specifications

Cerebrolysin

Molecular formula
Complex mixture — no single molecular formula (contains multiple peptide fragments and free amino acids derived from porcine brain proteins)
Molecular weight
Bioactive peptide components are all below 10 kDa (10,000 Da); the preparation contains a spectrum of peptide sizes
Half-life
Approximately 15-30 minutes (IV administration)
Bioavailability
~85-100% (intramuscular injection)
CAS number
Not assigned (biological mixture)

Semax

Molecular formula
C37H51N9O10S
Molecular weight
813.9 g/mol
Half-life
Several minutes to hours (intranasal effects persist longer)
Bioavailability
High via intranasal route (directly reaches brain)
CAS number
80714-61-0

Protocols

Dosing compared

Cerebrolysin

Intravenous

  • 10 mLOnce daily · 10-20 day course, repeated every 3-6 monthsA gentle starting dose given as a slow IV infusion (often diluted in saline). Used in dementia and recovery programs. [6][7]
  • 20-30 mLOnce daily · 10-21 day course, repeated in cyclesThe common clinical dose. Trials in vascular dementia used 20 mL daily, and stroke trials used 30 mL daily (diluted to about 100 mL saline) infused over ~30 minutes. [6][7]
  • 30-50 mLOnce daily · 10-21 days for stroke or severe brain injuryThe higher end used for acute stroke and severe traumatic brain injury, given as a diluted IV infusion under medical supervision. [7]

Intramuscular

  • 5-10 mLOnce daily · Up to 10-20 days per courseFor smaller doses, Cerebrolysin can be given as an intramuscular injection (no more than ~5 mL per injection site). Often used for milder cases or maintenance between IV cycles. [7]

Semax

Intranasal

  • 250-500 mcg/dayOnce or twice daily · 1-2 weeksCognitive/nootropic practice with the 0.1% solution; downstream BDNF/NGF effects persist 12-24 h so dosing is once to twice daily [1][2].
  • 500-900 mcg/dayDivided 2-3 times daily · 3-4 weeksMid-range nootropic practice dose; upregulates hippocampal BDNF/TrkB in animal models [1][2][3].

Applications

Best suited for

Cerebrolysin

Post-stroke neurorecovery and rehabilitation support
Cerebrolysin is particularly well-suited for individuals focused on post-stroke neurorecovery and rehabilitation support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [2][13].
Cognitive support in Alzheimer's disease and vascular dementia
Cerebrolysin is particularly well-suited for individuals focused on cognitive support in alzheimer's disease and vascular dementia. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][6].
Traumatic brain injury recovery and neuroprotection
Cerebrolysin is particularly well-suited for individuals focused on traumatic brain injury recovery and neuroprotection. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [14].
Age-related cognitive decline and mild cognitive impairment
Cerebrolysin is particularly well-suited for individuals focused on age-related cognitive decline and mild cognitive impairment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].

Semax

Students and Knowledge Workers
If your day revolves around learning, studying, or processing complex information, Semax can be a game-changer. It enhances memory consolidation and recall while improving your ability to focus for extended periods—perfect for exam prep or demanding projects [6][12].
Those Seeking Mental Clarity
Brain fog? Semax works by boosting BDNF—the protein that helps neurons communicate effectively. [1][2] Users often report feeling like the 'mental static' clears away, leaving sharper, more efficient thinking in its place.
Neuroprotection Seekers
Beyond immediate cognitive benefits, Semax offers protective effects for your brain cells. [9] It acts as an antioxidant (especially against copper toxicity) [4][8] and supports neuronal health—valuable for anyone concerned about long-term brain wellness.
Recovery Support (Under Medical Supervision)
In Russia, Semax is approved for helping stroke patients and those with traumatic brain injuries recover cognitive function. [6] While not FDA-approved for this use elsewhere, the research shows meaningful neuroprotective and neurorestorative properties [7][9].

Safety profile

Side effects

Cerebrolysin

Common

  • Injection site reactions
  • Headache
  • Dizziness and vertigo
  • Nausea and gastrointestinal discomfort
  • Agitation or restlessness
  • Fever

Uncommon

  • Allergic reaction

Serious

  • Severe hypersensitivity reaction

Semax

Common

  • Nasal irritation
  • Mild headache
  • Increased alertness

Uncommon

  • Temporary blood pressure increase
  • Dizziness

Serious

  • Allergic reaction

Research status

Safety & evidence

Cerebrolysin

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Cerebrolysin is an FDA-unregulated neuroprotective agent consisting of porcine brain-derived peptides and amino acids that has been used primarily in Eastern Europe and Asia. [8][12] Safety data is limited to observational clinical use and small open-label trials rather than rigorous randomized controlled trials with formal safety monitoring. As a complex mixture of undefined peptide fragments from animal sources, batch consistency and sterility cannot be guaranteed without pharmaceutical manufacturing standards. Potential allergic reactions to porcine proteins and transmissible spongiform encephalopathy (TSE) risks from animal-derived components have not been adequately ruled out.

Contraindications

  • Known hypersensitivity to Cerebrolysin or porcine-derived products
  • Severe renal impairment or renal failure
  • Status epilepticus or uncontrolled epilepsy
  • Pregnancy and breastfeeding — insufficient safety data

Semax

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Semax has been used clinically in Russia for over 25 years with an excellent safety profile. [7][12] It's approved there for treating stroke, cognitive impairment, and optic nerve diseases. [6] Studies consistently show minimal side effects, mostly limited to mild nasal irritation when using the spray form. [6][9] Unlike stimulants, Semax doesn't appear to cause tolerance, dependence, or withdrawal symptoms even with extended use.

Contraindications

  • Pregnancy or planning to become pregnant
  • Currently breastfeeding
  • History of seizures or epilepsy
  • Known allergy to ACTH-related peptides
  • Uncontrolled hypertension

Decision guide

Which is right for you?

Cerebrolysin

Choose Cerebrolysin if…

  • Post-stroke neurorecovery and rehabilitation support
  • Cognitive support in Alzheimer's disease and vascular dementia
  • Traumatic brain injury recovery and neuroprotection
  • Age-related cognitive decline and mild cognitive impairment

Semax

Choose Semax if…

  • Cognitive enhancement
  • Memory improvement
  • Focus and concentration
  • Neuroprotection